JVM Co. Ltd
JVM Co., Ltd. develops and sells automation systems and software of dispensing, packaging, and medication management for hospitals and pharmacies worldwide. It offers automatic dispensing and packaging systems; medication inspection and winding systems; medicine counting systems; canister management systems; automatic tablet counting systems; automatic tablet cutting systems; automatic PTP deblis… Read more
Market Cap & Net Worth: JVM Co. Ltd (054950)
JVM Co. Ltd (KQ:054950) has a market capitalization of $199.02 Million (₩291.40 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #17552 globally and #599 in its home market, demonstrating a -2.32% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JVM Co. Ltd's stock price ₩25300.00 by its total outstanding shares 11517968 (11.52 Million).
JVM Co. Ltd Market Cap History: 2015 to 2026
JVM Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $199.71 Million to $199.02 Million (-0.31% CAGR).
Index Memberships
JVM Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.61 Billion | 0.07% | #247 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.61 Billion | 0.07% | #247 of 1384 |
Weight: JVM Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
JVM Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JVM Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
JVM Co. Ltd's market cap is 0.00 times its annual revenue
0.74x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
JVM Co. Ltd's market cap is 0.01 times its annual earnings
2.58x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $199.71 Million | $88.46 Billion | $5.22 Billion | 0.00x | 0.04x |
| 2016 | $155.59 Million | $98.15 Billion | $11.10 Billion | 0.00x | 0.01x |
| 2017 | $208.99 Million | $106.18 Billion | $11.46 Billion | 0.00x | 0.02x |
| 2018 | $123.69 Million | $103.64 Billion | $8.16 Billion | 0.00x | 0.02x |
| 2019 | $110.50 Million | $110.14 Billion | $5.80 Billion | 0.00x | 0.02x |
| 2020 | $135.75 Million | $115.41 Billion | $10.44 Billion | 0.00x | 0.01x |
| 2021 | $106.88 Million | $115.83 Billion | $8.95 Billion | 0.00x | 0.01x |
| 2022 | $159.00 Million | $141.98 Billion | $15.76 Billion | 0.00x | 0.01x |
| 2023 | $208.46 Million | $157.09 Billion | $26.24 Billion | 0.00x | 0.01x |
| 2024 | $149.93 Million | $159.43 Billion | $28.84 Billion | 0.00x | 0.01x |
Competitor Companies of 054950 by Market Capitalization
Companies near JVM Co. Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to JVM Co. Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
JVM Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, JVM Co. Ltd's market cap moved from $199.71 Million to $ 199.02 Million, with a yearly change of -0.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩199.02 Million | -2.13% |
| 2025 | ₩203.35 Million | +35.62% |
| 2024 | ₩149.93 Million | -28.08% |
| 2023 | ₩208.46 Million | +31.10% |
| 2022 | ₩159.00 Million | +48.77% |
| 2021 | ₩106.88 Million | -21.27% |
| 2020 | ₩135.75 Million | +22.86% |
| 2019 | ₩110.50 Million | -10.66% |
| 2018 | ₩123.69 Million | -40.82% |
| 2017 | ₩208.99 Million | +34.32% |
| 2016 | ₩155.59 Million | -22.09% |
| 2015 | ₩199.71 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of JVM Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $199.02 Million USD |
| MoneyControl | $199.02 Million USD |
| MarketWatch | $199.02 Million USD |
| marketcap.company | $199.02 Million USD |
| Reuters | $199.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.